Chris is the Managing Partner of Bridgepoint Europe. Chris sits on the Firm’s Group Management Committee, the Investment Advisory Committee and chairs the weekly Operations Committee.
He currently sits on the board of Vermaat, and historical transactions include Element, PharmaZell, Vitamin Well, LGC, ERM, Pret A Manger and the delisting of Exova plc.
Chris has a BSc from Exeter University and is ACA qualified. Chris sits on the board of and is involved with charities in the Literacy and wider educational space.